Want to see JP:2395 full AI Analyst Report?

Shin Nippon Biomedical Laboratories, Ltd. (2395) Revenue

2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Revenue

Shin Nippon Biomedical Laboratories, Ltd. had a revenue of 7.87B in the quarter ending Jun 30, 2026, with -30.54%. This bring the company's revenue in the last twelve months to 33.92B, Decreased 4.28%. In the fiscal year ending Mar 31, 2026, Shin Nippon Biomedical Laboratories, Ltd. had annual revenue of 32.52B with 0.34% growth.

Revenue (ttm)

33.92B

Revenue Growth

1.72%

P/S Ratio

1.66

Revenue/Employee

¥19,360,095

Employees

1,680

Market Cap

¥54.04B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	32.52B	111.15M	+0.34%
Mar 31, 2025	32.41B	5.96B	+22.55%
Mar 31, 2024	26.45B	1.36B	+5.42%
Mar 31, 2023	25.09B	7.34B	+41.37%
Mar 31, 2022	17.75B	2.64B	+17.46%
Mar 31, 2021	15.11B	549.46M	+3.77%
Mar 31, 2020	14.56B	-1.10B	-7.01%
Mar 31, 2019	15.66B	-941.87M	-5.67%
Mar 31, 2018	16.60B	―	―